United States · FDA National Drug Code directory
Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1725_8a668a34-0be3-4aa9-8c87-3e9648f480cf
- Product NDC
- 71335-1725
- Form
- TABLET
- Composition / generic term
- Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171213
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 42 TABLET in 1 BOTTLE (71335-1725-0) · 71335-1725-0
- 30 TABLET in 1 BOTTLE (71335-1725-1) · 71335-1725-1
- 60 TABLET in 1 BOTTLE (71335-1725-2) · 71335-1725-2
- 90 TABLET in 1 BOTTLE (71335-1725-3) · 71335-1725-3
- 120 TABLET in 1 BOTTLE (71335-1725-4) · 71335-1725-4
- 14 TABLET in 1 BOTTLE, PLASTIC (71335-1725-5) · 71335-1725-5
- 28 TABLET in 1 BOTTLE, PLASTIC (71335-1725-6) · 71335-1725-6
- 6 TABLET in 1 BOTTLE, PLASTIC (71335-1725-7) · 71335-1725-7
- 10 TABLET in 1 BOTTLE, PLASTIC (71335-1725-8) · 71335-1725-8
- 21 TABLET in 1 BOTTLE, PLASTIC (71335-1725-9) · 71335-1725-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →